During this segment, Bruce Feinberg, DO, notes that oncologists commonly question the role of palliative care specialists, as oncologists consider pain management to be part of their job and are often concerned that referring patients to yet another type of oncology professional makes managing a patient’s disease more complex.
Ted Okon, MBA, executive director of the Community Oncology Alliance, remarks that not every patient needs to be referred to a palliative care specialist. Rather, he suggests that palliative care should be integrated into oncology practices.
Every healthcare professional within an oncology practice who contributes to a patient’s care needs to better understand what palliative care truly is, suggests Mr Okon. He adds that many people think that palliative care is end-of-life care, but it is not.
He advises that in many instances, the oncology practice can provide palliative care for patients, and that only patients in unique situations need a referral to a palliative care specialist.
Mr Okon says that the emphasis should always be placed on what is appropriate for the patient. “This is about the quality of life for the patient,” he adds.
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More
FDA Approves Pegcetacoplan for Rare Kidney Diseases C3G, Primary IC-MPGN in Patients 12 and Older
July 29th 2025The FDA approved pegcetacoplan (Empaveli; Apellis Pharmaceuticals) as the first treatment for patients 12 years and older with the rare, severe kidney diseases C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).
Read More